Global Implementation of ICH S6 : assessment of past accomplishments and future challenges.(WORKSHOP 1 : THE WAY TOXICITY EVALUATIONS OF BIO-PHARMACEUTICAL PRODUCTS SHOULD BE CONDUCTED (TOXICOLOGICAL QUESTIONS & ANSWERS-ISSUE 2002).ICH-S6)
スポンサーリンク
概要
著者
-
Cavagnaro Joy
Dabt Rac President Access Bio-former Fda Ich Topic Lead And Rapporteur Ich S6
-
Cavagnaro Joy
DABT, RAC, President, Access BIO-former FDA ICH Topic Lead and Rapporteur ICH S6